The latest round of funding for TOM Medications was hugely oversubscribed, at CHF 1.3 million, or over 120 percent. TOM Medications hopes the new funding will help boost its turnover, expand its …
Read Full Story at source (may require registration)
Latest posts by CHF Editor (see all)
- Technical talk: EUR/CHF rejecting monthly resistance - January 24, 2024
- USD/CHF moves higher to near 0.8680 as Fed members maintain a hawkish stance - January 24, 2024
- Holcim price target lowered by CHF 2 at Barclays - January 24, 2024